Anzeige
Mehr »
Login
Mittwoch, 23.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
KI-Energiekrise: Wie dieser Small Cap die nukleare Zukunft des Silicon Valley befeuern könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14399 | ISIN: SE0007074505 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
MAGNOLIA BOSTAD AB Chart 1 Jahr
GlobeNewswire (Europe)
2 Leser
Artikel bewerten:
(0)

Magnolia Bostad AB: Magnolia Bostad Interim report Jan-Jun 2024

During the first half of the year, we continued to focus on enhancing the company's liquidity and completing sustainable and high-quality projects for our buyers. In total, we delivered around 1,800 residential units to our buyers and we expect to complete and deliver around 1,500 more residential units in the second half of the year.

Johan Tengelin, CEO Magnolia Bostad:
"We are continuing to develop our projects for certification according to at least Swedish Green Building Council's (SGBC) silver certification, or an equivalent, with a focus on low energy consumption, a careful choice of materials and a good indoor and outdoor environment for residents. During the second quarter, we sold four projects comprising a total of 730 residences. These projects include a completed property in Brogårdstaden, Upplands-Bro, a project in Knivsta which is under construction and two completed properties on Gotland. Through these sales, we have freed up liquidity while reduced our level of indebtedness at the same time.

After a period when inflation and interest rates were high, we now see that inflation is moving towards the 2% target and that the Riksbank has started to reduce the key policy rate. We expect another two to three reductions in the second half of the year. Along with an increasing appetite for investment and a stabilization of contract prices, the conditions for a gradual recovery in new housing production are good. The residential transaction market, including rentals which is our largest segment, is showing signs of recovery and we are experiencing increased interest in our projects from investors.

We currently have 7,000 building permits with zoning plans in force, the majority of which are in the Stockholm region, which means that we are in a good position to be able to start a number of new projects in the quarters to come. I am proud of the accommodation we contribute to the housing market and would like to thank all our employees for the drive and commitment you have shown in maintaining our strong market position and execution capability through recent challenges. I have great faith in our business and look forward with confidence to an autumn where the playing field will hopefully be a lot livelier."

1 January-30 June 2024

  • Net sales amounted to SEK 1,331 m (158).
  • The operating loss was SEK 548 m (-286), of which SEK 84 m (-25) applies to changes in the value of investment properties.
  • The loss before tax for the period was SEK 708 m (-419) and the loss after tax was SEK 691 m (-422).

1 April-30 June 2024

  • Net sales amounted to SEK 1,279 m (101).
  • The operating loss was SEK 423 m (-179), of which SEK -36 m (-21) applies to changes in the value of investment properties.
  • The loss before tax for the period was SEK 501 m (-245) and the loss after tax was SEK 482 m (-246).

Events April 1-June 30, 2024

  • Sale of two properties, one in Knivsta and one in Upplands-Bro for a total of 524 residential units.
  • Sale of two properties on Gotland, one assisted living facility and one student residence, for a total of 210 homes.
  • Sale of the land intended for the development of the projects Bredden in Upplands Väsby and Senapsfabriken etapp 3 in Uppsala.
  • Received construction credit for a project in in Botkyrka where production is ongoing with 77 homes.
  • Carried out a downsizing of the organization to adapt it to changed market conditions.

Events after the end of the period

  • Obtained construction credit for a project in Borås where production is ongoing with 296 apartments.

For more information, please contact:
Johan Tengelin, CEO
johan.tengelin@magnoliabostad.se

Fredrik Westin, Deputy CEO & CFO
fredrik.westin@magnoliabostad.se
+46 72 720 00 06

This information is information that Magnolia Bostad AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-07-05 07:45 CEST.

About Magnolia Bostad
Magnolia Bostad AB, CIN 556797-7078, develops new residential properties, rental apartments, tenant-owned apartments, and community service properties in attractive locations in Sweden's growth areas and major cities. Housing is developed both for sale and self-management. Our work is based on a holistic approach where the operations are carried out in a way that promotes long-term, sustainable urban development. The company's bonds are listed on Nasdaq Stockholm. More information is available at www.magnoliabostad.se

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.